Evidence map›Paper›PMID 34833039›Full record

ArticleLife (Basel, Switzerland)2021

Henning Hanschmann, Stefan Rödiger, Toni Kramer, Katrin Hanschmann, Michael Steidle, Volker Fingerle, Carsten Schmidt, Werner Lehmann, Peter Schierack

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Henning HanschmannAttomol GmbH, 03205 Bronkow, Germany.
Stefan RödigerInstitute of Biotechnology, Faculty of Nature and Science, Brandenburg University of Technology Cottbus-Senftenberg, 01968 Senftenberg, Germany.ORCID 0000-0002-1441-6512
Toni KramerAttomol GmbH, 03205 Bronkow, Germany.
Katrin HanschmannAttomol GmbH, 03205 Bronkow, Germany.
Michael SteidleLaborärzte Sindelfingen, 71065 Sindelfingen, Germany.
Volker FingerleGerman National Reference Center for Borrelia, 85764 Oberschleißheim, Germany.ORCID 0000-0002-3835-5646
Carsten SchmidtInstitute of Biotechnology, Faculty of Nature and Science, Brandenburg University of Technology Cottbus-Senftenberg, 01968 Senftenberg, Germany.ORCID 0000-0002-7111-3315
Werner LehmannAttomol GmbH, 03205 Bronkow, Germany.
Peter SchierackInstitute of Biotechnology, Faculty of Nature and Science, Brandenburg University of Technology Cottbus-Senftenberg, 01968 Senftenberg, Germany.
Brandenburg University of Technology Cottbus-Senftenberg · DEKlinikum Sindelfingen-Böblingen · DE

Funding

Federal Ministry for Economic Affairs and Energy ZIM KF2212801SK9Federal Ministry of Education and Research 03IP611
6 · The paper itself

Abstract

backgroundLaboratory diagnosis of Lyme borreliosis refers to some methods with known limitations. Molecular diagnostics using specific nucleic acid probes may overcome some of these limitations.

methodsWe describe the novel reporter fluorescence real-time polymerase chain reaction (PCR) probe system

resultsUsing the

conclusionWe established a novel multiplex probe real-time PCR system, designated

Indexed as

B. Burgdorferi (sensu lato) complexBorreliadiagnosticLyme borreliosisreal-time PCR

Identifiers

PMID34833039
PMCPMC8624210
OpenAlexW3209099024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.